Further investigation of glucocorticoids and GR signals, as well as the functional interplay between the GR and the AR or the ERα/ERβ, in urothelial cancer may thus provide novel therapeutic options in patients with bladder cancer. The gene discussed is ESR2; the disease is urinary bladder carcinoma.